• 7025 malaria professionals are enjoying the free benefits of MalariaWorld today

chemotherapy

Malaria: passive case detection and healthcare providers' choices of chemotherapy

Author(s): 
Fehintola FA, Balogun ST
Reference: 
Afr J Med Med Sci 2010 Mar; 39(1):49-54.

Prompt diagnosis and treatment play a central role in the malaria control programme in sub Saharan Africa. However, in most cases the diagnoses are never confirmed either for lack of facility or disinterest of healthcare providers resulting in over-diagnosis.

Short Communication: Plasmodium vivax hypoxanthine-guanine phosphoribosyltransferase: A target for anti-malarial chemotherapy

Author(s): 
Dianne T., Dana H., et al.
Reference: 
Molecular and Biochemical Parasitology, Volume 173, Issue 2, October 2010, Pages 165-169
Contact email: 
luke.guddat@uq.edu.au

We have purified the recombinant Pv 6-oxopurine (PRTase) and compared its properties with the human and Pf enzymes. The Pv enzyme uses hypoxanthine and guanine with similar catalytic efficiency to the Pf enzyme but xanthine is not a substrate, hence we identify this enzyme as PvHGPRT.

Experimental Chemotherapy: Efficacy of Novel Oral Formulations of α/β Arteether against Multidrug-Resistant Malaria in Mice

Author(s): 
Renu Tripathia, Madhu Khannab, Anil Kumar Dwivedib
Reference: 
Chemotherapy 2010;56:178-183
Contact email: 
renu1113@rediffmail.com

The comparative antimalarial efficacy of eight different AE formulations was assessed at different time intervals in treated and control animals.

Syndicate content